Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)

Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Eugene R. Ahn, Miriam Yaniz, Yeon Ahn

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Antiphospholipid antibodies (APLA) are associated with anti-phospholipid syndrome (APS), a thrombotic disorder, but they are also frequently detected in immune thrombocytopenic purpura (ITP), a bleeding disorder. To investigate possible differences of APLA between these two disorders, we assayed IgG and IgM APLA by ELISA in 21 patients with ITP and 33 with APS. The APLA reacting against two protein target antigens, β2-glycoprotein 1 (β2GP1) and FVII/VIIa, and four phospholipids [cardiolipin (CL), phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE)] as well as lupus anticoagulant (LA) were analyzed. We made the following observations: (i) IgG and IgM antibodies to β2GP1 and IgM antibodies to FVII/VIIa were more common in APS than ITP, P < 0.05, while IgG antibodies against the phospholipids (aCL, aPC, aPS, aPE) were more common in ITP than APS, P < 0.05; (ii) multiple APLA (≥3 antigens) were more frequent in APS than ITP, P < 0.05; (iii) LA was frequently associated with APS but was absent in ITP; (iv) APLA is quite common in ITP: two-thirds were positive for at least one APLA. In summary, APLA are prevalent in ITP but their profile differs from APS. In APS, antibodies were predominantly against β2GP1 and 80% had positive LA, while in ITP the APLA reacted most often with the phospholipids without LA. The difference in APLA may result in opposite clinical manifestations in two disorders.

Original languageEnglish
Pages (from-to)391-396
Number of pages6
JournalAmerican Journal of Hematology
Volume81
Issue number6
DOIs
StatePublished - Jun 1 2006

Fingerprint

Antiphospholipid Antibodies
Idiopathic Thrombocytopenic Purpura
Antiphospholipid Syndrome
Lupus Coagulation Inhibitor
Immunoglobulin M
Phospholipids
Glycoproteins
Antibodies
Immunoglobulin G
Antigens
Cardiolipins
Phosphatidylserines
Phosphatidylcholines
Enzyme-Linked Immunosorbent Assay
Hemorrhage

Keywords

  • Antiphospholipid antibodies
  • Antiphospholipid syndrome
  • Bleeding
  • Immune thrombocytopenic purpura
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). / Bidot, Carlos J.; Jy, Wenche; Horstman, Lawrence L.; Ahn, Eugene R.; Yaniz, Miriam; Ahn, Yeon.

In: American Journal of Hematology, Vol. 81, No. 6, 01.06.2006, p. 391-396.

Research output: Contribution to journalArticle

Bidot, Carlos J. ; Jy, Wenche ; Horstman, Lawrence L. ; Ahn, Eugene R. ; Yaniz, Miriam ; Ahn, Yeon. / Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). In: American Journal of Hematology. 2006 ; Vol. 81, No. 6. pp. 391-396.
@article{9275125b328f438da9879be6c520ed6d,
title = "Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)",
abstract = "Antiphospholipid antibodies (APLA) are associated with anti-phospholipid syndrome (APS), a thrombotic disorder, but they are also frequently detected in immune thrombocytopenic purpura (ITP), a bleeding disorder. To investigate possible differences of APLA between these two disorders, we assayed IgG and IgM APLA by ELISA in 21 patients with ITP and 33 with APS. The APLA reacting against two protein target antigens, β2-glycoprotein 1 (β2GP1) and FVII/VIIa, and four phospholipids [cardiolipin (CL), phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE)] as well as lupus anticoagulant (LA) were analyzed. We made the following observations: (i) IgG and IgM antibodies to β2GP1 and IgM antibodies to FVII/VIIa were more common in APS than ITP, P < 0.05, while IgG antibodies against the phospholipids (aCL, aPC, aPS, aPE) were more common in ITP than APS, P < 0.05; (ii) multiple APLA (≥3 antigens) were more frequent in APS than ITP, P < 0.05; (iii) LA was frequently associated with APS but was absent in ITP; (iv) APLA is quite common in ITP: two-thirds were positive for at least one APLA. In summary, APLA are prevalent in ITP but their profile differs from APS. In APS, antibodies were predominantly against β2GP1 and 80{\%} had positive LA, while in ITP the APLA reacted most often with the phospholipids without LA. The difference in APLA may result in opposite clinical manifestations in two disorders.",
keywords = "Antiphospholipid antibodies, Antiphospholipid syndrome, Bleeding, Immune thrombocytopenic purpura, Thrombosis",
author = "Bidot, {Carlos J.} and Wenche Jy and Horstman, {Lawrence L.} and Ahn, {Eugene R.} and Miriam Yaniz and Yeon Ahn",
year = "2006",
month = "6",
day = "1",
doi = "10.1002/ajh.20571",
language = "English",
volume = "81",
pages = "391--396",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)

AU - Bidot, Carlos J.

AU - Jy, Wenche

AU - Horstman, Lawrence L.

AU - Ahn, Eugene R.

AU - Yaniz, Miriam

AU - Ahn, Yeon

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Antiphospholipid antibodies (APLA) are associated with anti-phospholipid syndrome (APS), a thrombotic disorder, but they are also frequently detected in immune thrombocytopenic purpura (ITP), a bleeding disorder. To investigate possible differences of APLA between these two disorders, we assayed IgG and IgM APLA by ELISA in 21 patients with ITP and 33 with APS. The APLA reacting against two protein target antigens, β2-glycoprotein 1 (β2GP1) and FVII/VIIa, and four phospholipids [cardiolipin (CL), phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE)] as well as lupus anticoagulant (LA) were analyzed. We made the following observations: (i) IgG and IgM antibodies to β2GP1 and IgM antibodies to FVII/VIIa were more common in APS than ITP, P < 0.05, while IgG antibodies against the phospholipids (aCL, aPC, aPS, aPE) were more common in ITP than APS, P < 0.05; (ii) multiple APLA (≥3 antigens) were more frequent in APS than ITP, P < 0.05; (iii) LA was frequently associated with APS but was absent in ITP; (iv) APLA is quite common in ITP: two-thirds were positive for at least one APLA. In summary, APLA are prevalent in ITP but their profile differs from APS. In APS, antibodies were predominantly against β2GP1 and 80% had positive LA, while in ITP the APLA reacted most often with the phospholipids without LA. The difference in APLA may result in opposite clinical manifestations in two disorders.

AB - Antiphospholipid antibodies (APLA) are associated with anti-phospholipid syndrome (APS), a thrombotic disorder, but they are also frequently detected in immune thrombocytopenic purpura (ITP), a bleeding disorder. To investigate possible differences of APLA between these two disorders, we assayed IgG and IgM APLA by ELISA in 21 patients with ITP and 33 with APS. The APLA reacting against two protein target antigens, β2-glycoprotein 1 (β2GP1) and FVII/VIIa, and four phospholipids [cardiolipin (CL), phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE)] as well as lupus anticoagulant (LA) were analyzed. We made the following observations: (i) IgG and IgM antibodies to β2GP1 and IgM antibodies to FVII/VIIa were more common in APS than ITP, P < 0.05, while IgG antibodies against the phospholipids (aCL, aPC, aPS, aPE) were more common in ITP than APS, P < 0.05; (ii) multiple APLA (≥3 antigens) were more frequent in APS than ITP, P < 0.05; (iii) LA was frequently associated with APS but was absent in ITP; (iv) APLA is quite common in ITP: two-thirds were positive for at least one APLA. In summary, APLA are prevalent in ITP but their profile differs from APS. In APS, antibodies were predominantly against β2GP1 and 80% had positive LA, while in ITP the APLA reacted most often with the phospholipids without LA. The difference in APLA may result in opposite clinical manifestations in two disorders.

KW - Antiphospholipid antibodies

KW - Antiphospholipid syndrome

KW - Bleeding

KW - Immune thrombocytopenic purpura

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33646867483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646867483&partnerID=8YFLogxK

U2 - 10.1002/ajh.20571

DO - 10.1002/ajh.20571

M3 - Article

C2 - 16680753

AN - SCOPUS:33646867483

VL - 81

SP - 391

EP - 396

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 6

ER -